Gilead is nearing a deal to buy biotech Immunomedics and its prized breast-cancer drug for more than $20 billion, say people familiar with the matter
Gilead Sciences Inc. is nearing a deal to buy biotech Immunomedics Inc. and its prized breast-cancer drug for more than $20 billion, according to people familiar with the matter.
Immunomedics has a market value of roughly $10 billion following a recent surge in its stock, meaning that Gilead is paying up to secure ownership of the company.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WSJ News Exclusive | SoftBank Nears $40 Billion Deal to Sell Arm Holdings to NvidiaThe Japanese technology conglomerate is nearing another big asset sale—a deal selling Arms Holdings to Nvidia for more than $40 billion, according to people familiar with the matter.
Weiterlesen »
SoftBank nears deal to sell Arm Holdings to Nvidia for more than $40 billion - WSJSoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than $40 billion, the Wall Street Journal reported on Saturday, citing sources.
Weiterlesen »
WSJ News Exclusive | Second Top Female Executive at Bridgewater Says Firm Paid Her Less Than MenBridgewater's top female executive is sparring with the firm after learning she earned less than male counterparts, people familiar with the matter said
Weiterlesen »
WSJ News Exclusive | Tommy Hilfiger Asks $47.5 Million for Greenwich EstateAt a time when New Yorkers fleeing the pandemic are driving up Greenwich property values, Tommy Hilfiger is listing yet another Greenwich home, a sprawling French Normandy-style estate, for $47.5 million
Weiterlesen »
WSJ News Exclusive | Rural California Counties Accuse Newsom of Withholding Covid-19 FundsLeaders of some rural California counties are accusing Gov. Gavin Newsom of improperly withholding federal coronavirus relief funds to force them to slow business reopenings.
Weiterlesen »